Epidemiology of chronic obstructive pulmonary disease
L Ruvuna, A Sood - Clinics in Chest Medicine, 2020 - chestmed.theclinics.com
Chronic obstructive pulmonary disease (COPD) is a slowly progressing chronic respiratory
disorder. It is characterized by an obstructive ventilatory pattern, which is often partially …
disorder. It is characterized by an obstructive ventilatory pattern, which is often partially …
Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine
VE Ortega, DA Meyers - Journal of allergy and clinical immunology, 2014 - Elsevier
Pharmacogenetics is being used to develop personalized therapies specific to subjects from
different ethnic or racial groups. To date, pharmacogenetic studies have been primarily …
different ethnic or racial groups. To date, pharmacogenetic studies have been primarily …
[HTML][HTML] Focus: Health Equity: An Overview of Health Disparities in Asthma
MF Perez, MT Coutinho - The Yale journal of biology and medicine, 2021 - ncbi.nlm.nih.gov
Asthma is a heterogeneous disease characterized by inflammation in the respiratory airways
which manifests clinically with wheezing, cough, and episodic periods of chest tightness; if …
which manifests clinically with wheezing, cough, and episodic periods of chest tightness; if …
Asthma in Hispanics. An 8-year update
FJ Rosser, E Forno, PJ Cooper… - American journal of …, 2014 - atsjournals.org
This review provides an update on asthma in Hispanics, a diverse group tracing their
ancestry to countries previously under Spanish rule. A marked variability in the prevalence …
ancestry to countries previously under Spanish rule. A marked variability in the prevalence …
Genetic ancestry influences asthma susceptibility and lung function among Latinos
Background Childhood asthma prevalence and morbidity varies among Latinos in the
United States, with Puerto Ricans having the highest and Mexicans the lowest. Objective To …
United States, with Puerto Ricans having the highest and Mexicans the lowest. Objective To …
Chronic obstructive pulmonary disease secondary to household air pollution
NA Assad, J Balmes, S Mehta… - … in respiratory and …, 2015 - thieme-connect.com
Approximately 3 billion people around the world cook and heat their homes using solid fuels
in open fires and rudimentary stoves, resulting in household air pollution. Household air …
in open fires and rudimentary stoves, resulting in household air pollution. Household air …
Health disparities in asthma
E Forno, JC Celedón - American journal of respiratory and critical …, 2012 - atsjournals.org
Although asthma affects all ethnic groups, the burden from this disease is disproportionately
shared by certain minority groups and the economically disadvantaged. The prevalence of …
shared by certain minority groups and the economically disadvantaged. The prevalence of …
From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
Background The lifetime risk of developing clinical COPD among smokers ranges from 13%
to 22%. Identifying at-risk individuals who will develop overt disease in a reasonable …
to 22%. Identifying at-risk individuals who will develop overt disease in a reasonable …
A pilot study linking endothelial injury in lungs and kidneys in chronic obstructive pulmonary disease
F Polverino, ME Laucho-Contreras… - American journal of …, 2017 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) frequently have
albuminuria (indicative of renal endothelial cell injury) associated with hypoxemia …
albuminuria (indicative of renal endothelial cell injury) associated with hypoxemia …
Disparities in mortality of hispanic patients with cystic fibrosis in the United States. A national and regional cohort study
J Rho, C Ahn, A Gao, GS Sawicki, A Keller… - American journal of …, 2018 - atsjournals.org
Rationale: Patients of Hispanic origin with cystic fibrosis (CF) are the largest growing
minority, representing 8.5% of patients with CF in the United States. No national survival …
minority, representing 8.5% of patients with CF in the United States. No national survival …